SRRK stock forecast
Our latest prediction for Scholar Rock Holding Corp.'s stock price was made on the May 29, 2018 when the stock price was at 16.12$.
In the short term (2weeks), SRRK's stock price should outperform the market by 5.74%. During that period the price should oscillate between -2.23% and +4.15%.
In the medium term (3months), SRRK's stock price should outperform the market by 10.08%. During that period the price should oscillate between -4.83% and +10.49%.Get email alerts
About Scholar Rock Holding Corp.
Scholar Rock Holding Corp. is a biopharmaceutical company, which engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.70$ per share.
The book value per share is 4.42$
Three months stock forecastMay 29, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|